10-Q
XBRL
EDGE THERAPEUTICS INC 10-Q 3-31-2016
- Company
- PDS Biotechnology Corp
- Filed
- May 3, 2016
- Period of Report
- March 31, 2016
- Accession Number
- 0001140361-16-063034
A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →